Catechol-Containing Compounds are a Broad Class of Amyloid Inhibitors: Redox State is a Key Determinant of the Inhibitory Activities
P. Velander, L. Wu, S. B. Hildreth, N. J. Vogelaar, B. Mukhopadhyay, S. Zhang, R. F. Helm, B. Xu
Abstract
Mechanisms of amyloid inhibition remains poorly understood, in part because most protein targets of amyloid assembly are partially unfolded or intrinsically disordered, which hinders detailed structural characterization of protein-inhibitor complexes and structural-based mechanistic elucidation. Herein we employed a small molecule screening approach to identify inhibitors against three prototype amyloidogenic proteins: amylin, A{beta} and tau. One remarkable class of inhibitors identified was catechol-containing compounds and redox-related quinones/anthraquinones. Further mechanistic studies determined that the redox state of the broad class of catechol-containing compounds is a key determinant of the amyloid inhibitor activities.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Catechol-Containing Compounds are a Broad Class of Amyloid Inhibitors: II. Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in HIP Rats
L. Wu, P. Velander, … B. Xu·bioRxiv·Dec 13, 2020
- Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease
G. T. Heller, F. A. Aprile, … M. Vendruscolo·bioRxiv·Sep 16, 2020
- An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ
Patrick Stalder, T. Serdiuk, … Paola Picotti·bioRxiv·Dec 18, 2023
- A peptide strategy for inhibiting different protein aggregation pathways in disease
T. Garfagnini, L. Ferrari, … A. Friedler·bioRxiv·Oct 22, 2022
- Identification of Catechins Binding Pockets in Monomeric Aβ42 Through Ensemble Docking and MD Simulations
C. Chavez Gracia, R. Firouzi, … M. Karttunen·bioRxiv·Feb 9, 2022
- Clusterin in Alzheimer's disease: an amyloidogenic inhibitor of amyloid formation
P. M. Spatharas, G. I. Nasi, … V. A. Iconomidou·bioRxiv·Apr 2, 2021